Cai Y, et al. - The researchers carried out a systematic review and meta-analysis to compare the glucose-lowering efficacy and safety of alogliptin between Asian and non-Asian patients with type 2 diabetes. In improving glycemic levels, alogliptin was more effective in Asians than in other ethnic populations. To explore the potential mechanisms, future studies were needed.